Trial Profile

A Randomised, Double-Blind, Placebo-Controlled Study of Single and Multiple Ascending Doses of PN-235 in Healthy Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 22 Feb 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Icotrokinra (Primary)
Indications Unspecified
Focus Adverse reactions
Sponsors Protagonist Therapeutics

Most Recent Events

03 Nov 2021 According to a Protagonist Therapeutics media release, the company has been completed this phase 1 study.
03 Nov 2021 Status changed from recruiting to completed, according to a Protagonist Therapeutics media release.
04 May 2021 According to a Protagonist Therapeutics media release, the company expects to complete this study in the second half of 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com